Skip to main content
Home / Current Drug Therapy, Volume 6, Number 2
Current Drug Therapy publishes frontier reviews on all the latest advances in drug therapy. The journal's aim is to publish the highest quality review articles in the field. Topics covered include: new and existing drugs, therapies and medical devices.

The journal is essential reading for all researchers and clinicians involved in drug therapy.

Publisher: Bentham Science Publishers

More about this publication?
Volume 6, Number 2, 2011

Articles

Gels and Jellies as a Dosage Form for Dysphagia Patients: A Review
pp. 79-86(8)
Authors: A. Satyanarayana, Dixit; K. Kulkarni, Parthasarathi; G. Shivakumar, Hosakote

Favourites:
ADD

Nanoparticles, Promising Carriers in Drug Targeting: A Review
pp. 87-96(10)
Authors: M. Ram, Yaduvanshi; K.S. Yadav, Hemant; N. Singh, Mangla; G. Shivakumar, Hosakote

Favourites:
ADD

Palliative Tumor Control by Trabectedin in Pediatric Advanced Sarcoma
pp. 97-99(3)
Authors: A. Farah, Roula; C. Nasser, Soumana; A. Sabbagh, Racha; B. Dina, Pele; A. Eid, Toufic

Favourites:
ADD

Periodontitis and Periodontal Drug Delivery Systems: A Review
pp. 100-112(13)
Authors: S. Pendekal, Mohamed; K. Tegginamat, Pramod

Favourites:
ADD

Serendipity of Erythromycin in the Management of Periprosthetic Inflammation
pp. 113-120(8)
Authors: Ren, Weiping; Blasier, Ralph; C. Markel, David

Favourites:
ADD

Management of Painful Symptoms with Duloxetine: A Review of the Efficacy in Pre-Clinical and Clinical Studies
pp. 121-136(16)
Authors: J. Robinson, Michael; Ahl, Jonna; L. Meyers, Adam; H. McCarberg, Bill; Iyengar, Smriti

Favourites:
ADD

Pulmonary Drug Delivery System: A Novel Approach for Drug Delivery
pp. 137-151(15)
Authors: Singh, Anupama; Malviya, Rishabha; K. Sharma, Pramod

Favourites:
ADD

Advancement in Vaccinology: New Era in Formulation Strategies
pp. 152-159(8)
Authors: S. Khan, Mohammed; V. Gowda, D.; G. Shivakumar, Hosakote

Favourites:
ADD

Share Content

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content